A detailed history of Deutsche Bank Ag\ transactions in 89bio, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 52,706 shares of ETNB stock, worth $413,742. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,706
Previous 42,418 24.25%
Holding current value
$413,742
Previous $339,000 15.04%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$7.36 - $9.66 $75,719 - $99,382
10,288 Added 24.25%
52,706 $390,000
Q2 2024

Aug 14, 2024

SELL
$7.31 - $10.9 $43,706 - $65,171
-5,979 Reduced 12.35%
42,418 $339,000
Q1 2024

May 15, 2024

SELL
$8.13 - $13.77 $2.69 Million - $4.55 Million
-330,443 Reduced 87.22%
48,397 $563,000
Q4 2023

Feb 14, 2024

BUY
$6.66 - $16.03 $2.31 Million - $5.55 Million
346,276 Added 1063.37%
378,840 $4.23 Million
Q3 2023

Nov 09, 2023

SELL
$15.06 - $19.41 $11.6 Million - $15 Million
-771,532 Reduced 95.95%
32,564 $502,000
Q2 2023

Aug 14, 2023

BUY
$14.15 - $22.03 $11.3 Million - $17.5 Million
795,659 Added 9430.59%
804,096 $15.2 Million
Q3 2022

Nov 14, 2022

SELL
$3.02 - $7.0 $117,592 - $272,566
-38,938 Reduced 82.19%
8,437 $49,000
Q2 2022

Aug 11, 2022

BUY
$2.09 - $4.02 $70,380 - $135,373
33,675 Added 245.8%
47,375 $152,000
Q1 2022

May 13, 2022

SELL
$3.45 - $14.99 $2,208 - $9,593
-640 Reduced 4.46%
13,700 $52,000
Q4 2021

Feb 11, 2022

SELL
$11.15 - $19.66 $646,744 - $1.14 Million
-58,004 Reduced 80.18%
14,340 $187,000
Q3 2021

Nov 04, 2021

SELL
$14.91 - $21.31 $2,698 - $3,857
-181 Reduced 0.25%
72,344 $1.42 Million
Q2 2021

Aug 11, 2021

BUY
$17.42 - $28.0 $4,302 - $6,916
247 Added 0.34%
72,525 $1.36 Million
Q1 2021

May 13, 2021

SELL
$20.22 - $26.73 $10,190 - $13,471
-504 Reduced 0.69%
72,278 $1.71 Million
Q4 2020

Feb 16, 2021

BUY
$23.16 - $28.08 $1.61 Million - $1.95 Million
69,337 Added 2012.69%
72,782 $1.77 Million
Q3 2020

Nov 12, 2020

BUY
$24.34 - $38.82 $47,219 - $75,310
1,940 Added 128.9%
3,445 $89,000
Q2 2020

Aug 13, 2020

BUY
$19.93 - $31.2 $7,972 - $12,480
400 Added 36.2%
1,505 $30,000
Q1 2020

May 14, 2020

BUY
$16.4 - $41.77 $1,984 - $5,054
121 Added 12.3%
1,105 $28,000
Q4 2019

Feb 14, 2020

BUY
$19.75 - $33.44 $19,434 - $32,904
984 New
984 $25,000

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $365M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.